ARCHIVES

GAO Suggests No Limit On Indirect Costs But Ceiling On Total Costs

This article is from The Cancer Letter archive.

Vol. 05 No. 36 | September 7, 1979

Download PDF Visit The Full Archive

Related Articles

Beta Blockers Negate Harmful Recurrence Risks of ACE Inhibitors

April 29, 2011

Approvals and Applications: European Committee Signs Off On Paxene for KS reatment

March 5, 1999

Cancer Groups Urge Support For Comprehensive Cancer Care Legislation.

June 29, 2007

New CREGs Announced In Epidemiology, Viruses, Carcinogenesis

April 23, 1976

Cancer Informatics: NCI Writing Dictionary To Standardize Data Reported In Trials

November 13, 1998

NCI Advisors Approve Expansion Of CCOPs, Minority-Based CCOPs; Approve Reissuance Of BMT Network RFA, RFPs For Preclinical Drug Studies

November 13, 2009